CompletedNot Applicable

GB34 Acupuncture in Acute Cholecystitis

Turkey (Türkiye)30 participantsStarted 2021-07-01

Plain-language summary

The purpose of this pilot study is to investigate the effects of GB34 acupuncture, performed as adjuvant to standard medical treatment, on clinical response and laboratory parameters of patients with a diagnosis of acute cholecystitis.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed and hospitalised patients with mild acute cholecystitis Exclusion Criteria: * Pregnant women * Immunosuppressive patients * Patients with intermediate and severe acute cholecystitis * Patients with acalculous acute cholecystitis * Patients with uncontrolled diabetes mellitus * Patients with collegen tissue diseases * Patients with malignancies * Patients who are using anti-coagulant or anti-aggregant medications * Patients with blood diseases * Patients with BMI\>35

What they're measuring

Perceived pain

Timeframe: From hospital admission (baseline) until hospital discharge, with VAS assessments performed every 12 hours, assessed up to a maximum of 168 hours.

Analgesic dosage

Timeframe: From hospital admission (baseline) until hospital discharge, assessed up to a maximum of 168 hours.

Trial details

NCT IDNCT04960189

SponsorNigde Omer Halisdemir University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-10

View on ClinicalTrials.gov More Acute Cholecystitis trials